Ovarian Cysts: Types, Diagnosis, and When to Seek Care
Ovarian cysts are fluid-filled sacs that form on or within the ovaries, affecting people with ovaries across all reproductive age groups and into the postmenopausal years. This page covers the major cyst classifications, how they develop and resolve, the diagnostic tools used to identify them, and the clinical thresholds that distinguish watchful waiting from urgent intervention. Understanding these distinctions matters because while most ovarian cysts are benign and self-resolving, a subset carries risks including torsion, rupture, or malignancy that require prompt clinical evaluation.
Definition and Scope
The Office on Women's Health (OWH), a division of the U.S. Department of Health and Human Services, defines ovarian cysts as sacs filled with fluid that form on the ovaries. The OWH notes that most ovarian cysts are functional — meaning they arise as a normal part of the menstrual cycle — and resolve without treatment within 8 to 12 weeks.
Prevalence is significant. The majority of premenopausal people with ovaries develop at least one functional cyst during their lifetime, though most never cause noticeable symptoms. Postmenopausal ovarian cysts occur in roughly 18% of postmenopausal women, according to data reviewed by the American College of Obstetricians and Gynecologists (ACOG), and warrant a different risk calculus than premenopausal cysts because the ovaries are no longer producing follicles.
The regulatory context for women's health in the United States places oversight of diagnostic standards and gynecologic care protocols under a combination of federal agency guidance — primarily from the U.S. Food and Drug Administration (FDA) regarding imaging and laboratory standards — and professional society guidelines from ACOG and the Society of Gynecologic Oncology (SGO).
How It Works
Ovarian cysts form through distinct biological mechanisms depending on their type. The classification structure below represents the primary diagnostic categories recognized in ACOG Practice Bulletin No. 174:
Functional Cysts (Most Common)
- Follicular cysts — A follicle containing a developing egg fails to rupture at ovulation and continues to fill with fluid. These typically measure between 2.5 cm and 5 cm in diameter and resolve spontaneously within one to three menstrual cycles.
- Corpus luteum cysts — After ovulation, the corpus luteum (the follicle remnant) seals and accumulates fluid or blood. These can grow to 10 cm or larger and may rupture, causing acute pelvic pain.
Non-Functional Cysts
- Dermoid cysts (mature teratomas) — Contain tissue types such as hair, sebum, or calcified material derived from embryonic cells. Dermoid cysts account for approximately 20% of all ovarian tumors and have a low malignant transformation rate, estimated below 2% (ACOG Practice Bulletin No. 174).
- Endometriomas — Cysts formed when endometrial tissue implants on the ovary, filling with dark, old blood. Often called "chocolate cysts," these are strongly associated with endometriosis and can impair ovarian reserve.
- Cystadenomas — Develop from the outer surface of the ovary; serous cystadenomas can reach 30 cm or more in diameter, while mucinous cystadenomas may grow even larger.
- Polycystic-appearing ovaries — Multiple small follicular cysts distributed peripherally within the ovary, associated with polycystic ovary syndrome (PCOS), though the cyst pattern itself is not pathognomonic.
The primary diagnostic tool for ovarian cysts is transvaginal ultrasound, which characterizes cyst morphology — size, wall thickness, internal echoes, and septation — to inform risk stratification. Serum CA-125 is used as an adjunct in postmenopausal patients or when malignancy is suspected, but ACOG cautions that CA-125 lacks sufficient specificity in premenopausal populations due to elevation by benign conditions including menstruation, fibroids, and pelvic inflammatory disease.
Common Scenarios
Clinical presentations of ovarian cysts fall into three broad patterns:
Asymptomatic discovery — A cyst is identified incidentally during pelvic ultrasound performed for another indication, such as fertility and conception workup or routine prenatal imaging. This is the most common presentation; the cyst is typically simple, unilocular, and less than 5 cm.
Pelvic pain and pressure — Larger cysts or those undergoing torsion (twisting of the ovarian pedicle) produce unilateral pelvic pain, pressure, bloating, or dyspareunia. Ovarian torsion constitutes a surgical emergency; blood supply to the ovary is interrupted, and necrosis can begin within hours of onset. The Women's Health Authority index provides orientation to the full scope of gynecologic conditions covered across this reference.
Rupture with acute onset — A ruptured corpus luteum cyst can cause sudden, severe unilateral lower abdominal pain accompanied by intraperitoneal bleeding. Hemodynamic instability from significant hemorrhage requires emergency evaluation. Rupture rates are higher in patients on anticoagulant therapy.
Cysts associated with ovarian cancer risk represent a distinct scenario requiring specialist-directed evaluation, particularly in postmenopausal patients with complex cyst morphology (thick septa, solid components, or internal vascularity on Doppler imaging).
Decision Boundaries
ACOG Practice Bulletin No. 174 establishes the primary framework for managing adnexal masses in reproductive-age and postmenopausal patients. The decision boundaries hinge on four variables:
- Menopausal status — Premenopausal simple cysts under 10 cm may be observed with repeat ultrasound at 8–12 weeks. Postmenopausal simple cysts under 7 cm with a normal CA-125 can be managed with surveillance in most patients, per ACOG guidance.
- Cyst morphology — Simple, unilocular, anechoic cysts carry substantially lower malignancy risk than complex cysts with thick septa (>3 mm), mural nodules, or solid components.
- Cyst size — Functional cysts exceeding 10 cm are less likely to resolve spontaneously and carry higher torsion risk. Dermoid cysts larger than 6 cm are typically referred for surgical removal to prevent torsion.
- Symptom acuity — Signs consistent with torsion — sudden unilateral pain, nausea, vomiting, and absent blood flow on Doppler ultrasound — require emergency surgical consultation regardless of cyst size or morphology.
The Society of Gynecologic Oncology (SGO) recommends referral to a gynecologic oncologist when a postmenopausal patient presents with a complex mass, an elevated CA-125, ascites, or a first-degree family history of ovarian or breast cancer (SGO Clinical Practice Statement). The FDA's guidance on ultrasound devices establishes performance standards for the imaging equipment central to this diagnostic pathway.
Hormonal contraception is sometimes used in premenopausal patients with recurrent functional cysts to suppress ovulation, though ACOG notes the evidence that oral contraceptives accelerate resolution of existing cysts is limited.
References
- Office on Women's Health (OWH) — Ovarian Cysts
- American College of Obstetricians and Gynecologists (ACOG) — Practice Bulletin No. 174: Management of Adnexal Masses
- Society of Gynecologic Oncology (SGO) — Clinical Practice Statement: Referral of Women with Adnexal Masses
- U.S. Food and Drug Administration (FDA) — Ultrasound Imaging
- U.S. Department of Health and Human Services — Office on Women's Health
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)